INVEST Feasibility

A Single Arm, Feasibility Study of Minimally Invasive Endoscopic Surgical Treatment with Apollo/Artemis for Supratentorial Intracerebral Hemorrhage

INVEST Feasibility is a Mount Sinai physician led, multicenter single- arm feasibility study that intends to provide an assessment of enrollment and follow-up feasibility for patients who present with a supratentorial intracerebral hemorrhage (ICH) and are being treated with the Apollo or Artemis Minimally Invasive Surgical Treatment (MIES) through neurological and functional assessments. Patients who are unable to be enrolled in the feasibility study are referred to the INVEST Registry study, where patients are only responsible for completing the assessments and are not treated with the Apollo or Artemis MIES.

Learn more: https://clinicaltrials.gov/study/NCT02654015